KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
2021 · Cell Reports · 36 citations
https://doi.org/10.1016/j.celrep.2021.109056
C
Catherine S. Forconi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
526
Citations
12
h-index
18
i10-index
Catherine S. Forconi is an academic researcher from University of Massachusetts Chan Medical School. The author has contributed to research in topics: Immune Cell Function and Interaction & Malaria Research and Control & Cytomegalovirus and herpesvirus research. The author has an h-index of 12, co-authored 56 publications.
ORCID: 0000-0001-7358-5546Papers by this author
worksSensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia
2019 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-019-56472-1
The microbiota of pregnant women with SARS-CoV-2 and their infants
2023 · Microbiome · 10 citations
https://doi.org/10.1186/s40168-023-01577-z
Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children
2021 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-021-90596-7
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools
2024 · PLoS ONE · 4 citations
https://doi.org/10.1371/journal.pone.0307568
Rituximab is associated with an increased risk of malaria among adult lymphoma patients in Malawi: a prospective observational cohort
2025 · EClinicalMedicine · 1 citations
https://doi.org/10.1016/j.eclinm.2025.103597
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat